Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

127 results about "Carnitine" patented technology

Carnitine (β-hydroxy-γ-N-trimethylaminobutyric acid, 3-hydroxy-4-N,N,N-trimethylaminobutyrate) is a quaternary ammonium compound involved in metabolism in most mammals, plants, and some bacteria. Carnitine may exist in two isomers, labeled D-carnitine and L-carnitine, which are both biologically active. At room temperature, pure carnitine is a white powder, and a water-soluble zwitterion with low toxicity. Carnitine only exists in animals as the L-enantiomer, and D-carnitine is toxic because it inhibits the activity of L-carnitine. Carnitine, derived from an amino acid, is found in nearly all organisms and animal tissue. Carnitine is the generic expression for a number of compounds that include L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine. It is most accumulated in cardiac and skeletal muscles as it accounts for 0.1% of its dry matter. It was first derived from meat extracts in 1905, therefore the name carnitine is derived from Latin "carnus" or flesh. The body synthesizes enough carnitine from lysine side chains to keep up with the needs of energy production in the body as carnitine acts as a transporter of long-chain fatty acids into the mitochondria to be oxidized and produce energy. Some individuals with genetic or medical disorders (such as preterm infants) cannot make enough, so this makes carnitine a conditionally essential nutrient for them.

Feed premix for improving chicken quality

The invention provides a feed premix for improving chicken quality. The fresh-keeping agent is prepared from the following components in percentage by weight: 5%-15% of a flavor enhancing component, 10%-25% of a tenderness improving component, 3%-10% of an antioxidant fresh-keeping component, 2%-3% of a function enhancing component and the balance of a carrier and a diluent, the function strengthening component is prepared from beta-alanine embedded citronella essential oil and konjac glucomannan zymolyte; the flavor enhancing component comprises a rosemary extract, a yeast culture and curcumin in a mass ratio of (2-4): (1-3): 1; the tenderness improving component comprises conjugated linoleic acid, L-carnitine modified by glutamine transaminase and betaine in a mass ratio of (3-5): (2-4): 1; the antioxidant fresh-keeping component is vitamin E and tea polyphenol in a mass ratio of (1-2): 1. Through multi-component synergism and functional targeting optimization, a three-dimensional quality improvement system with enhanced flavor, improved tenderness, oxidation resistance and fresh keeping is constructed, so that the chicken quality is comprehensively upgraded.
Owner:BAIHE (SHANGHAI) BIOTECHNOLOGY CO LTD

A meal replacement powder for weight loss in obese patients and a method for preparing the same

The application belongs to the technical field of functional food, and particularly discloses a meal replacement powder for weight loss of obese patients and a preparation method thereof. The meal replacement powder comprises whey protein powder, composite dietary fiber (containing at least two kinds of konjac powder and the like), functional carbohydrate, functional fat (containing medium-chain fatty acid and the like), and composite vitamins, minerals, functional additives (L-carnitine and the like), and stability additives. The preparation comprises raw material pretreatment, small material premixing, large material mixing, microencapsulation of fat-soluble components, total mixing, sterilization and packaging, and the key lies in that the fat-soluble components are wrapped by wall materials and spray dried into microcapsules. The meal replacement powder can balance nutrition, strengthen satiety, promote fat metabolism, avoid muscle loss and electrolyte imbalance, has a shelf life of 12 months at room temperature, has good palatability, has good weight loss effect (average weight loss of 5.8 kg in 2 months), has no adverse reactions, and is suitable for long-term weight loss diet management of obese patients.
Owner:石霞

Anti-aging capsule compounded by PQQ and mitochondrial nutrients

The invention relates to an anti-aging capsule compounded by PQQ and mitochondrial nutrients, and discloses an anti-aging capsule which is prepared by synergistically compounding a plurality of mitochondrial nutrients according to a scientific proportion and supplementing high-purity raw materials and slow-release dosage forms to realize energy metabolism activation and anti-oxidation synergistic intervention. Therefore, the anti-aging capsule systematically delays aging through multi-target regulation and control of mitochondrial functions. The capsule is characterized by comprising the following components in parts by weight: 1-20 mg of pyrroloquinoline quinone disodium salt (PQQ), 20-100 mg of coenzyme Q10, 50-200 mg of L-carnitine tartrate, 10-100 mg of alpha-lipoic acid, 50-300 mg of nicotinamide mononucleotide (NMN) or nicotinamide nucleoside (NR), and 10-50 [mu] g of selenoprotein or organic selenium yeast, and a capsule carrier comprises 100 mg of gelatin or a plant-derived capsule shell, 180 mg of microcrystalline cellulose, 5 mg of magnesium stearate and 5 mg of silicon dioxide.
Owner:JIANGSU SHAREJOY HEALTH TECH CO LTD

Astragaloside synergistic composition as well as preparation method and application thereof

The invention discloses an astragaloside synergistic type composition as well as a preparation method and application of the astragaloside synergistic type composition. Comprising the following components: 8 to 16 parts of astragaloside, 20 to 40 parts of a honeysuckle flower extract, 10 to 20 parts of L-carnitine, 0.1 to 0.5 part of selenium yeast, 3 to 8 parts of diammonium glycyrrhizinate, 5 to 15 parts of taurine, 8 to 20 parts of a fructus forsythiae extract, 2 to 7 parts of vitamin E, 12 to 32 parts of hydroxypropyl-beta-cyclodextrin, 2 to 10.5 parts of maltodextrin, 1 to 7 parts of Arabic gum, 10 to 20 parts of lactose, 1 to 3 parts of zinc gluconate and 2 to 5 parts of magnesium stearate. 1-3 parts of vitamin C, 1-5 parts of xanthan gum and 1-3 parts of lecithin. The composition has a wide application prospect in preparation of veterinary drugs or veterinary food additives.
Owner:JIANGXI CHENGBIXIN BIOTECHNOLOGY CO LTD

Dried blood spot liquid chromatography-mass spectrometry detection method adaptive to 7 types of metabolites

The invention belongs to the technical field of biological medicine, and discloses a dry blood spot liquid chromatography-mass spectrometry detection method adaptive to 7 metabolites. According to the method, a pH / polarity double-trigger microcapsule solvent carrier system is adopted, high-polarity extraction solvents, medium-polarity extraction solvents and low-polarity extraction solvents are packaged in the pH / polarity double-trigger microcapsule solvent carrier system in a layered mode, the solvents are released in sequence according to local pH and polarity changes in the extraction process, and amino acid, acyl carnitine, organic acid, bile acid, steroid, fatty acid and glycometabolism intermediate products are efficiently extracted respectively. The method disclosed by the invention breaks through the inherent limitation of a traditional static solvent system, solves the problem of unbalanced recovery rate caused by insufficient solvent suitability in dry blood spot extraction of seven metabolites with great polarity span, and remarkably improves the accuracy, reproducibility and coverage range of a DBS-LC-MS / MS platform in synchronous detection of multi-component metabolites; and reliable technical support is provided for newborn inherited metabolic disease screening, endocrine disease diagnosis and drug metabolism research.
Owner:SHANGHAI BIOTREE

Complete-cycle nutrition-enhanced goat hybridization breeding method

The invention relates to the technical field of livestock and poultry breeding, in particular to a goat hybridization breeding method capable of achieving complete-cycle nutrition enhancement. The core of the method is that systematic nutrition intervention runs through the whole breeding process. Before hybridization, performing differential nutrition pretreatment on the parents for 60 days: feeding the female parents with a breeding nutrition enhancer added with components such as D-chiro-inositol and N-acetylcysteine, and supplementing sperm motility enhancer containing acetylated L-carnitine and ergothioneine to the male parents. In the gamete treatment stage, the oocytes are subjected to in-vitro maturation culture in a special culture solution containing components such as D-chiro-inositol and a growth differentiation factor 9; after the sperms are subjected to gradient centrifugal screening, completing in-vitro fertilization in an optimized fertilization culture solution; after the embryos develop into blastocysts in the sequential culture system, carrying out laparoscopic transplantation, and carrying out staged precise nutrition culture on the pregnant ewes. According to the method, through multi-level nutrition enhancement, the reproductive capacity of the goats and the growth performance of offspring are effectively improved.
Owner:XINJIANG ACAD OF ANIMAL SCI

Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity

PendingUS20260137646A1Nervous disorderImmunological disordersCompulsive disordersNervous system
Administration of pentadecanoylcarnitine or pentadecanoic acid is provided for prevention, management or treatment of aggression, allergies, allergic rhinitis, Alzheimer's disease, anxiety and anxiety disorders, amyotrophic lateral sclerosis, arthritis, asthma, atherosclerosis, attention-deficit hyperactivity disorder, bipoloar disorder, brain damage, cancer, cardiovascular disease, cholestatic pruritis, depression, chronic obstructive pulmonary disease (COPD), cocaine abuse, cough, dermatitis, depression, drug-seeking behavior, gastrointestinal disorders, facial erythema associated with rosacea, glaucoma, hepatic diseases, hyperactive bladder, hypersensitivity disorders, hypertension, impulsivity, inflammation, mental disorders and conditions, metabolic disorders, migraines, nasal and sinus congestion, nausea, neuropathic pain with and symptoms of multiple sclerosis, neurological and neuropsychiatric disorders, obesity, obsessive-compulsive disorders, opioid-induced respiratory depression, osteoarthritis, pain, Parkinson disease, pathological gambling, peptic ulcers, schizophrenia, sleep disorders, spinal cord injury, tardive dyskinesia, tics and behavioral problems with Tourette's syndrome; as well as for supporting appetite, cardiovascular health, hematologic health, memory, metabolic health, mood, prolonged REM sleep, renal health, sexuality, sociability and metabolic, hematological, renal, and weight loss.
Owner:EPITRACKER INC

Composition for assisting in improving eosinophilic esophagitis and application thereof

The invention relates to the technical field of compositions, and particularly discloses a composition for assisting in improving eosinophilic esophagitis and application of the composition. The composition for assisting in improving eosinophilic esophagitis provided by the invention comprises an iron source, a zinc source and L-carnitine. By optimizing the components of the composition and specifically limiting the proportion of the iron source, the zinc source and the L-carnitine in the composition, esophageal epithelial hyperplasia can be effectively reversed, the number of bifidobacteria is increased, the number of enterobacter and esophageal tissue eosinophilic granulocytes is reduced, the level of IL-13 cell factors is reduced, and the curative effect is improved. Further, the effect of remarkably assisting in improving eosinophilic granulocytic esophagitis is achieved.
Owner:JUNLEBAO DAIRY GRP CO LTD

A direct qPCR amplification reagent, amplification kit and application for whole blood samples

This invention discloses direct amplification qPCR reagents, kits, and applications for whole blood samples. The amplification reagents include: a composite hot-start DNA polymerase system, a buffer system, a surfactant, an anti-contamination system, and an anti-inhibition enhancer system. The composite hot-start DNA polymerase system is obtained by mixing antibody-modified hot-start Taq enzyme and antibody-modified Taq1C2 mutant Taq enzyme in a predetermined ratio. The buffer system includes Tris-HCl, MgCl2, (NH4)2SO4, and KCl. The surfactants include Tween-20 and NP-40. The anti-contamination system includes UDG enzyme and dNTPs, wherein the dNTPs are composed of dATP, dGTP, dCTP, dTTP, and dUTP. The anti-inhibition enhancer system includes D-trehalose, L-carnitine, DMSO, BSA, and SSB single-chain binding protein.
Owner:河南远止生物技术有限公司 +2

Cell culture medium supplement as well as preparation method and application thereof

The invention discloses a cell culture medium supplement as well as a preparation method and application thereof, and relates to the technical field of cell biology. The supplement comprises DL-alpha-tocopheryl acetate, linolenic acid, ethanolamine, L-carnitine hydrochloride, 3, 3 ', 5-triiodoL-sodium thyrosinate, and serum albumin. As a cell culture additive with definite chemical components and simple composition, the cell culture additive can replace a traditional culture system with unknown chemical components or too complex composition, and is used for supporting proliferation, differentiation and characterization analysis of cells. The culture medium additive is clear in chemical component, simple to prepare, stable in effect and relatively low in cost, can promote in-vitro proliferation and oxidation resistance of cells including human embryonic stem cells and mesenchymal stem cells, and has important application value in actual production.
Owner:UNIV OF MACAU

Metabolite marker for colorectal cancer diagnosis and application thereof

The invention relates to a metabolite marker for early diagnosis of colorectal cancer as well as application and a device of the metabolite marker. The marker comprises sulfate, ubiquinone-1, a deoxycholic acid glycine conjugate, demethylchlorophyllin, 3-(3, 5-diiodine-4-hydroxyphenyl) lactate, vitamin K1, O-decanoyl-L-carnitine, sedoheptulose 1, 7-diphosphoric acid, cholesterol-docosahexaenoic acid ester and acyl AMP (adenosine monophosphate). The marker combination has excellent performance in colorectal cancer detection, AUROC can reach 0.97, and noninvasive screening and early diagnosis of colorectal cancer can be accurately, quickly and simply realized.
Owner:MACAU UNIV OF SCI & TECH

Application of marker in preparation of kit for diagnosing chronic obstructive pulmonary disease

PendingCN121805600AComponent separationDisease diagnosisDiseaseAklanonic acid
The invention discloses application of a marker to preparation of a kit for diagnosing chronic obstructive pulmonary diseases. According to the application disclosed by the invention, the accuracy of diagnosing the chronic obstructive pulmonary disease by using (R)-3-hydroxytetradecanoic acid alone or in combination with the azelayl platelet activating factor is relatively high; on the basis of combination of (R)-3-hydroxytetradecanoic acid and an azelayl platelet activating factor, the compound is prepared. The compound can be further combined with one or two of 1-hexadecyl-2-(5-oxovaleryl)-sn-glycerol-3-phosphorylcholine, 1-O-hexadecyl-SN-glycerol-3-choline phosphoric acid, lauroyl-L-carnitine and beta-acetyl-gamma-O-alkyl-L-alpha-phosphatidylcholine to be used for diagnosing the chronic obstructive pulmonary disease. Therefore, a diagnostic kit for diagnosing the chronic obstructive pulmonary disease can be prepared on the basis of the scheme, and the kit contains a compound standard substance corresponding to the scheme and can also contain an internal standard compound for mass spectrum quantitative analysis.
Owner:HENAN UNIV OF CHINESE MEDICINE

Metabolic markers for distinguishing hypertrophic cardiomyopathy from left ventricular hypertrophy and uses thereof

ActiveCN120064663BHypertrophic cardiomyopathyAdenosine diphosphate
The application belongs to the technical field of molecular biology, and particularly relates to metabolic markers for distinguishing hypertrophic cardiomyopathy and left ventricular hypertrophy and application. The application analyzes the metabolome of hypertrophic cardiomyopathy (HCM) patients, left ventricular hypertrophy (LVH) patients caused by non-hypertrophic cardiomyopathy and healthy people, finds that carnitine C16:2, carnitine C14:0, carnitine C16:0, carnitine C18:0 and carnitine C18:1 are differentially expressed in HCM patients and LVH patients, pyridoxine phosphate, ito acid, adenosine monophosphate, adenosine diphosphate and adenosine triphosphate are differentially expressed in HCM patients and healthy people, lysine base, methyl glutamic acid, acetyl proline, malate semialdehyde and citramalate are differentially expressed in LVH patients and healthy people, and ROC curve analysis shows excellent prediction effect, strong specificity and high sensitivity.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

Cream with efficient mild whitening effect and preparation method thereof

The invention provides efficient mild whitening cream and a preparation method thereof. The raw materials of the cream comprise five phases A and E, the phase C contains 0.1-3% of a mixed solution of isosorbide dimethyl ether and hydroxyl pinacolone retinoate, and the phase D contains 0.01-0.1% of L-carnitine. Wherein the hydroxyl pinacolone retinoate can be specifically combined with an RAR / RXR (Region Receptor / Receptor X Receptor), and the expression of an MITF (Microphthalmia-associated Transcription Factor) gene is reduced, so that the melanogenesis is inhibited; l-carnitine promotes fatty acid beta-oxidation and enhances ATP synthesis to indirectly regulate and control AMPK activity; aMPK enhances transcriptional activity of a tretinoin receptor through phosphorylation of the tretinoin receptor, so that the AMPK and hydroxyl pinacolone retinoate exert a synergistic effect, jointly enhance whitening activity, effectively improve the phenomena of color spots and dark skin and promote the skin color to be uniform, bright and white; meanwhile, the isosorbide dimethyl ether can promote the transdermal absorption of the hydroxyl pinacolone retinoate, the L-carnitine and the related active ingredients.
Owner:SHANGHAI CHUANGMEIYAN COSMETICS TECH CO LTD

Application of reagent for detecting plasma metabolism marker combination in preparation of product for diagnosing breast cancer

The invention discloses application of a reagent for detecting a plasma metabolism marker combination in preparation of a product for diagnosing breast cancer, and belongs to the field of breast cancer markers. According to the application of the reagent for detecting the plasma metabolism marker combination in preparing the product for diagnosing the breast cancer, the plasma metabolism marker combination comprises dehydroepiandrosterone sulfate, acylcarnitine 12: 0 and taurodeoxycholic acid. The plasma metabolism marker combination has high specificity, high sensitivity and non-invasiveness when being used for breast cancer detection, so that a subject can conveniently and safely receive detection, and the plasma metabolism marker combination is suitable for screening and detection of large-scale common people and is beneficial to early screening, early diagnosis and early treatment of breast cancer.
Owner:HARBIN METANOTITIA INC

Nutrional composition for treating and / or preventing muscle wasting

The invention pertains to a nutritional composition comprising taurine, carnitine and a mixture of low- molecular-weight polyphenols derived from lychee fruit and green tea leaves. Further, the invention pertains to a nutritional composition comprising taurine, carnitine and a mixture of low-molecular-weight polyphenols derived from lychee fruit and green tea leaves for use as a medicament, more particularly for therapeutic use in treating and / or preventing muscle wasting.
Owner:NV NUTRICIA

Injection composition for lipolysis

The present invention relates to an injection composition for lipolysis, which is safe and effective, and more specifically, to an injection composition for lipolysis, which comprises: one or more compounds selected from the group consisting of hyaluronidase and pentoxifylline, and one or more compounds selected from the group consisting of hyaluronidase, pentoxifylline, pentoxifylline, pentoxifylline, pentoxifylline, pentoxifylline, pentoxifylline, pentoxifylline, pentoxifylline, pentoxifylline and pentoxifylline. 5 to 10% (v / v) of carnitine (Carnitine); and lidocaine (Lidocaine); and normal saline. As a composition having both safety and efficacy, the injection composition for lipolysis of the present invention has an excellent lipolysis effect, does not cause a yo-yo phenomenon over time, and thus has a characteristic of not causing side effects such as skin depression.
Owner:姜旼材

Nutritional composition for alzheimer's disease population or high-risk population, and preparation method therefor

A nutritional composition for an Alzheimer's disease population or a high-risk population, prepared from the following raw materials in parts by weight: 170-300 parts of proteinaceous substances, 85-250 parts of fatty substances, 450-770 parts of carbohydrates, 10-155 parts of dietary fiber substances, 1.2-3.5 parts of trace minerals, 47-180 parts of macro minerals, 2.0-8.3 parts of vitamins, 0.1-1.0 parts of taurine, 0.05-0.5 parts of L-carnitine, and 0.9-1.0 parts of lactoferrin. The composition is rich in high-quality animal and plant proteins, fatty acids, various vitamins, minerals, and water-soluble dietary fibers, has remarkable effects in slowing down the occurrence and development of Alzheimer's disease, and is suitable for an Alzheimer's disease population or a high-risk population to eat.
Owner:HAINAN XINGZHENG NUTRITION ENGINEERING CO LTD

A combined biomarker for predicting intradialytic hypotension and a kit for detecting the same

The application discloses a combined biomarker for predicting hypotension in dialysis and a detection kit thereof, and the combined biomarker is 3-hydroxyisovaleryl carnitine, valine, phenylalanine and decadienoyl carnitine. The combined biomarker can better predict the risk of hypotension in dialysis of a subject in a discovery phase (AUC 0.804, sensitivity 77.5%) and an independent sample verification phase (AUC 0.804, sensitivity 90.0%). The detection method has the advantages of simple operation, few detection indexes, low cost, good specificity, high sensitivity, good repeatability and the like, and provides a simple and reliable method for early identification of a high-risk person of hypotension in dialysis and implementation of prevention intervention.
Owner:NINGBO MEDICAL CENT LIHUILI HOSPITACL

Food composition for enhancing exercise tolerance as well as preparation method and application of food composition

The invention provides a food composition for enhancing exercise tolerance as well as a preparation method and application of the food composition, and relates to the technical field of foods. The invention discloses a food composition. The composition is prepared from the following components in parts by weight: 6 to 16 parts of bovine blood oligopeptide, 10 to 20 parts of collagen, 1 to 3 parts of beta-carotene, 15 to 26 parts of radix codonopsis extract, 13 to 25 parts of pleurotus nebrodensis polysaccharide, 10 to 30 parts of isomaltooligosacharide, 5 to 10 parts of creatine, 4 to 10 parts of taurine, 0.2 to 0.6 part of vitamin B1, 0.2 to 0.6 part of vitamin B6, 5 to 15 parts of guarana extract, 4 to 12 parts of green tea extract and 4 to 12 parts of green coffee extract. 2-5 parts of L-carnitine, 5-12 parts of cordyceps militaris, 5-12 parts of red ginseng and 5-12 parts of lucid ganoderma. The obtained food composition has the effects of resisting fatigue and improving hypoxia tolerance, and is applied to preparation of food with the effects of enhancing exercise tolerance, resisting hypoxia and relieving fatigue.
Owner:HENAN ZHONGWO IND CO LTD

Use of urolithin a co-crystal to improve urolithin a water solubility and bioavailability, methods of preparation and compositions thereof

PendingCN122325427AUrolithinAqueous solubility
This invention provides urolithin A cocrystals, their preparation methods, compositions, and applications. Specifically, this invention provides a urolithin A cocrystal with high bioavailability, wherein the urolithin A cocrystal is selected from the group consisting of: urolithin A-proline cocrystals, urolithin A-carnitine cocrystals, urolithin A-nicotinamide cocrystals, or urolithin A-creatine cocrystals. Compared to urolithin itself, the urolithin A cocrystals of this invention exhibit high stability, a significantly lower melting point, and significantly improved solubility and bioavailability. Furthermore, the preparation method is simple, easy to control, and has good reproducibility, allowing for stable acquisition of the target cocrystal. The composition containing the cocrystal, prepared by grinding, has high yield, low cost, and is suitable for large-scale production.
Owner:COCRYSTAL HEALTH IND (ZHEJIANG) CO LTD

Dietary fiber composition capable of reducing calorie intake and slowing down digestion speed and preparation method of dietary fiber composition

The invention provides a dietary fiber composition capable of reducing calorie intake and slowing down digestion speed and a preparation method thereof, and belongs to the technical field of weight control. The feed additive is prepared from the following raw materials in parts by weight: 18-20 parts of sodium carboxymethyl cellulose, 1-2 parts of lecithin, 15-18 parts of modified konjac glucomannan, 4-8 parts of L-carnitine, 4-8 parts of a white kidney bean extract, 1-2 parts of chlorogenic acid and 3-5 parts of probiotics. The dietary fiber composition capable of reducing calorie intake and slowing down digestion speed, prepared by the invention, regulates fat metabolism in a targeted manner through multiple metabolism, reduces calorie intake, slows down digestion speed, improves glucose metabolism in a body, improves calorie consumption of the body, reduces fat hoarding, improves satiety, reduces food intake, prolongs the duration time of satiety, and has the efficacy of reducing calorie intake and slowing down digestion speed. Therefore, a good body weight control effect is achieved, and wide application prospects are achieved.
Owner:BEIJING XINGFU ENERGY HEALTH TECH CO LTD

EGCG supramolecule with antioxidant, liver protection and fat reduction effects, preparation method and composition thereof

PendingCN122302307AEfficacyTrimethyloxamine
This invention discloses an EGCG supramolecular compound with antioxidant, liver-protective, and fat-reducing effects, its preparation method, and composition. The supramolecular compound is formed by non-covalent bonding between epigallocatechin gallate (EGCG) and ligand molecules containing trimethylamine and carboxyl groups; the supramolecular compound has a co-amorphous structure; the ligand molecules containing trimethylamine and carboxyl groups are betaine, ergothioneine, or L-carnitine. This invention can solve the problems of low stability and bioavailability of EGCG. It can significantly improve the solubility of EGCG and its ligands, including betaine, L-carnitine, and ergothioneine, reduce the hygroscopicity of EGCG and its ligands, including betaine, L-carnitine, and ergothioneine, and enhance the stability and bioavailability of EGCG and its ligands, including betaine, L-carnitine, and ergothioneine.
Owner:SHENZHEN SIYOMICRO BIO TECH CO LTD

Special biscuit for improving sperm fertilization ability of boars under heat stress and processing method thereof

PendingCN121647342AFood processingAnimal feeding stuffNutritional statusPhysiology
The invention discloses a special biscuit for improving sperm fertilization ability of boars under heat stress and a processing method thereof, and the biscuit comprises the following components by weight: 10% of grease; the grease comprises DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), and the weight ratios of the DHA and the EPA in the grease are respectively 30% and 35%; 8%-18% of an amino acid component; the weight ratio of lysine to methionine to tryptophan to threonine to arginine in the amino acid component is 100 to (26 to 38) to (18 to 32) to (70 to 90) to (60 to 120); the vitamin component comprises 0.6%-1.0% of vitamin A, 1%-3% of L-carnitine, 0.5%-1% of vitamin E and 0.5%-1% of vitamin D; the trace element components comprise 0.01%-0.1% of nano selenium, 0.1%-1% of nano zinc and 0.02% of organic chromium; and the balance of corn starch. The special biscuit can improve the sperm motility of the boars and improve the reproductive nutrition status of the boars, the special biscuit is designed into independent quantitative solid blocks, and the problems that powdery additives are inaccurate in metering, uneven in mixing and waste in throwing can be solved.
Owner:SICHUAN AGRI UNIV

Clostridium butyricum microecological preparation composition for improving sperm quality of livestock and poultry

The invention relates to the field of microorganisms, and particularly discloses a clostridium butyricum microecological preparation composition for improving the sperm quality of livestock and poultry. The preparation method comprises the following steps: selecting materials such as cortex phellodendri to prepare mixed powder, using materials such as zinc-rich edible yeast powder to prepare a pasty bacterial colony proliferation culture medium, using materials such as the mixed powder and clostridium butyricum dry powder to prepare activated clostridium butyricum bacterial sludge, and performing mixed fermentation on the activated clostridium butyricum bacterial sludge and the pasty bacterial colony proliferation culture medium; and finally, pouring a mixed solution formed by xanthan gum, fructo-oligosaccharide and purified water into mixed dry powder of materials such as the bacteria-rich fermentation mixture, L-carnitine and the like to obtain a blend wet material, and drying the blend wet material to obtain the microecological preparation composition. The microecological preparation composition is added into the feed, so that the palatability and the nutrient utilization degree of the feed can be effectively improved, the ingestion and digestion of livestock and poultry are promoted, the organism immunity of the livestock and poultry is enhanced, and the semen quality of the livestock and poultry is improved on the premise of avoiding overdraft of the livestock and poultry.
Owner:SHAANXI AGRICULTURE & FORESTRY VOCATIONAL & TECHNICAL UNIVERSITY

Slow-release pharmaceutical composition for treating cardiomyopathy and preparation device thereof

The invention relates to the technical field of biological medicines, in particular to a sustained-release pharmaceutical composition for treating cardiomyopathy and a preparation device thereof. An existing preparation is fast in metabolism and difficult to act for a long time in myocardial tissue. Every 10 ml of the pharmaceutical composition comprises 1 g of levocarnitine as a raw material medicine, 48 mg of sodium benzoate, 34 mg of DL-malic acid and 5 mg of saccharin sodium as auxiliary materials, hydrochloric acid used for adjusting the PH value to 4.3-4.7, and purified water added to 10 ml. Through an auxiliary material system in the composition, especially DL-malic acid, the release rate of the medicine can be adjusted, and a physical and chemical basis is provided for realizing a slow release effect, so that the medicine can be released more gently in vivo, and the effective blood concentration of the medicine can be maintained for a longer time, thereby achieving the purpose of continuously supplying energy to myocardial cells, and further achieving the aim of continuously supplying energy to the myocardial cells. The defects that the half-life period is short and the drug effect is not continuous in the prior art are overcome.
Owner:ZHEJIANG CHANGDIAN PHARM TECH DEV CO LTD

High-protein aquatic feed for improving meat quality of micropterus salmoides and preparation method of high-protein aquatic feed

The invention relates to the technical field of aquaculture feeds, and particularly discloses a high-protein aquatic feed for improving meat quality of micropterus salmoides and a preparation method of the high-protein aquatic feed. The preparation method of the feed comprises the following steps: mixing the carnitine, the astaxanthin, the phytosterol, the tributyrin, the yucca extract, the meat structure-effect core premix, the monocalcium phosphate and the choline chloride to obtain a core mixture; extruding and puffing bran, mixing the extruded and puffed bran with the core mixture, and performing negative pressure treatment to obtain a feed core compound; and finally, carrying out glucose-chitosan-zinc lysine inner layer coating and sodium alginate gel outer layer encapsulation to prepare the high-protein aquatic feed. The activity of functional components is effectively protected through a three-stage protection system, targeted slow release of intestinal tracts is achieved, the bioavailability is remarkably improved, the growth performance of largemouth bass can be remarkably improved through the obtained feed, the feed coefficient and the abdominal fat rate are reduced, meanwhile, the muscle hardness, elasticity and collagen content are improved, and the meat quality is comprehensively improved.
Owner:JIANGSU AGRI ANIMAL HUSBANDRY VOCATIONAL COLLEGE